A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation-Reference-Cited by-同舟云学术

A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation

Published:2022-08-01 Issue:5 Volume:276 Page:868-874
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Pinto-Marques Hugo,Cardoso Joana,Silva Sílvia,Neto João L.,Gonçalves-Reis Maria,Proença Daniela,Mesquita Marta,Manso André,Carapeta Sara,Sobral Mafalda,Figueiredo Antonio,Rodrigues Clara,Milheiro Adelaide,Carvalho Ana,Perdigoto Rui,Barroso Eduardo,Pereira-Leal José B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference60 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Prognostic factors for post-recurrent survival in hepatocellular carcinoma after curative resection;Saito;Anticancer Res,2019

3. Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities;Golabi;Medicine,2017

4. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients;Bismuth;Ann Surg,1993

5. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Artificial Intelligence for Liver Diseases: A Survey from the EASL Congress 2024;JHEP Reports;2024-09

2. Use of machine learning models for the prognostication of liver transplantation: A systematic review;World Journal of Transplantation;2024-03-18

3. Analytical validation and algorithm improvement of HepatoPredict kit to assess hepatocellular carcinoma prognosis before a liver transplantation;Practical Laboratory Medicine;2024-03

4. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma;Journal of Applied Genetics;2024-02-12

5. Pushing the limits of treatment for hepatocellular carcinoma;Current Opinion in Organ Transplantation;2023-11-30